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Abstract
Background: Most Canadians die in hospital, and yet, many express a preference to die at home. Place of death is
the result of the interaction among sociodemographic, illness- and healthcare-related factors. Although home death
is sometimes considered a potential indicator of end-of-life/palliative care quality, some determinants of place of death
are more modifiable than others. The objective of this systematic review was to evaluate the determinants of home
and nursing home death in adult patients diagnosed with an advanced, life-limiting illness.
Methods: A systematic literature search was performed for studies in English published from January 1, 2004 to
September 24, 2013 that evaluated the determinants of home or nursing home death compared to hospital death in
adult patients with an advanced, life-limiting condition. The adjusted odds ratios, relative risks, and 95 % confidence
intervals of each determinant were extracted from the studies. Meta-analyses were performed if appropriate. The
quality of individual studies was assessed using the Newcastle-Ottawa scale and the body of evidence was assessed
according to the GRADE Working Group criteria.
Results: Of the 5,900 citations identified, 26 retrospective cohort studies were eligible. The risk of bias in the studies
identified was considered low. Factors associated with an increased likelihood of home versus hospital death included
multidisciplinary home palliative care, preference for home death, cancer as opposed to other diagnoses, early referral
to palliative care, not living alone, having a caregiver, and the caregiver’s coping skills.
Conclusions: Knowledge about the determinants of place of death can be used to inform care planning between
healthcare providers, patients and family members regarding the feasibility of dying in the preferred location and
may help explain the incongruence between preferred and actual place of death.
Modifiable factors such as early referral to palliative care, presence of a multidisciplinary home palliative care team were
identified, which may be amenable to interventions that improve the likelihood of a patient dying in the preferred
location. Place of death may not be a very good indicator of the quality of end-of-life/palliative care since it is
determined by multiple factors and is therefore dependent on individual circumstances.
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Background
Most Canadians die in hospital. In 2011, 65 % of deaths
in Canada occurred in acute care hospitals [1], and yet,
many, 63 % according to an Ontario survey [2], express
a preference to die at home.
The needs of terminally ill patients vary, consequently,
certain places of death may be more appropriate for
some patients than others [2]. According to a conceptual
model [3], place of death results from an interplay of
factors that can be grouped into 3 main domains: illness
(type of disease, level of disability), individual, and envir-
onment. Individual-related factors include sociodemo-
graphic characteristics and patients’ preferences with
regards to place of death [3]. Environment-related fac-
tors can be divided into health care input (home care,
hospital bed availability, hospital admissions); social sup-
port (living arrangements, patient’s social support net-
work, caregiver preferences); and macrosocial factors
(historical trends) [3]. It is important to note that the
preference for home death may decrease with the pro-
gression of the illness [4].
Although the location of death, and home death in
particular, is sometimes considered as a potential indi-
cator of the quality of end-of-life/palliative care [5], it is
possible that some determinants of place of death are
more modifiable than others and a comprehensive exam-
ination of these important factors and how modifiable
they are is needed.
Two systematic reviews evaluating the determinants of
home death in cancer patients have been published in
the past decade [3, 6], one of them evaluated a single de-
terminant, type of cancer [6]. Several studies examining
the determinants of different places of death in patients
with and without malignant diseases have been pub-
lished since these reviews. Studies have shown that satis-
faction with end-of-life care is improved when patients
die in their preferred location [7]; an understanding of
the factors that influence the location of death could
better inform discussions among healthcare providers,
patients and their families regarding patient preferences
and the feasibility of dying in the preferred location. This
knowledge could also inform policy decisions aimed at
improving patients’ likelihood of dying in their preferred
place of death.
Accordingly, we conducted an updated systematic review
of the literature to evaluate the determinants of home and
nursing home death among adult patients with advanced,
life-limiting malignant or non-malignant illnesses to in-
form discussions about preferred place of death.
Research methods
A literature search was performed using Ovid MEDLINE,
Ovid MEDLINE In-Process and Other Non-Indexed Cita-
tions, Ovid Embase, EBSCO Cumulative Index to Nursing
& Allied Health Literature (CINAHL), and EBM Reviews,
for studies published from January 1, 2004, and September
24, 2013. The full search strategy is available in Additional
file 1. The literature search start date reflects the end of
the literature search of the 2006 systematic review on the
determinants of home death [3]. Title and abstracts were
screened and the full text of potentially relevant articles
were obtained for further assessment. Study eligibility was
assessed by a single reviewer for both the title and abstract
screening and full text review, however, studies with un-
certain eligibility were reviewed and discussed with a sec-
ond reviewer.
The conduct and reporting of this review was per-
formed according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses: The PRISMA
Statement [8]. The PRISMA checklist is available in
Additional file 2.
Eligibility criteria
We examined studies that evaluated, a priori, the deter-
minants of death at home or nursing homes compared
to hospital. Studies published in English between January
1, 2004, and September 24, 2013 in adult patients diag-
nosed with an advanced, life-limiting condition not ex-
pected to improve or stabilize were considered. For
observational studies, only those that used multivariable
analyses to adjust for potential confounders were in-
cluded. Duplicate publications and studies that did not
report either the adjusted odds ratio (OR) or relative risk
(RR), and 95 % confidence intervals (CI) for any of the
determinants of place of death specified below were ex-
cluded. Similarly, studies in which more than one place
of death was combined in the results (for instance hos-
pital, hospices and nursing home deaths combined as in-
stitutional deaths) were excluded.
The following determinants were evaluated as specified
a priori: type of disease, symptoms such as pain, hospital
admissions, functional status, availability of home care,
palliative care in the place of residence, patient and/or
family preference for place of death, living arrangements,
presence and support for informal caregivers.
Quality assessment
The risk of bias in the cohort studies included was assessed
using the Newcastle-Ottawa Scale (NOS) [9]. In the NOS, a
study can receive a maximum of nine stars on items related
to the selection of the patient population (4 stars), the com-
parability of the groups (2 stars) and the assessment of the
outcomes of interest (3 stars) [9]. The quality of the body of
evidence for each determinant was examined according to
the Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) Working Group criteria
[10]. Factors considered in the assessment included study
design, risk of bias, inconsistency, indirectness, imprecision,
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and publication bias [10]. The overall quality was deter-
mined to be high, moderate, low, or very low using a step-
wise, structural methodology.
Data extraction
Pre-determined forms were used to extract data on study
design and characteristics, patients’ characteristics, and
study results. The following study characteristics were ex-
tracted: year of publication, number of participants, coun-
try where the study was conducted, setting, study design,
patient population, and determinants of home and nurs-
ing home death included in the multivariable analyses.
The following patient characteristics were extracted: age,
sex, type of underlying disease, preferred place of death,
and actual place of death.
Data analysis
The adjusted ORs or RRs, and 95 % CIs for each deter-
minant of home or nursing home death compared to hos-
pital death were extracted from the studies. Heterogeneity
was measured using the I2 statistic. [11] Meta-analyses
were performed when more than one study was available
for a given determinant and in the absence of considerable
heterogeneity using the inverse variance method and a
random effects model. Stratified analyses were performed
for variables such as type of disease, setting, or country
where the study was conducted if deemed necessary to ex-
plain the heterogeneity. Meta-analyses were performed
using Review Manager (RevMan, version 5.2. Copenhagen:
The Nordic Cochrane Centre, The Cochrane Collabor-
ation, 2012).
Results
The database search yielded 5,899 citations (duplicates re-
moved), one additional study was identified through con-
sultation with experts. Figure 1 shows the breakdown of
when and for what reason citations were excluded from
the analysis.
Twenty-six retrospective cohort studies using multi-
variable analyses met the inclusion criteria [2, 12–36].
Tables 1 and 2 show the characteristics of the patients
included in these studies. Further information on study
design and adjustment factors included in the multivari-
able analyses is available in Additional file 3.
The results of the studies evaluating the determinants
of home and nursing home deaths are shown below.
Determinants of home death
Twenty-one retrospective cohort studies evaluated the
determinants of home versus hospital death using multi-
variable analyses [2, 12, 13, 17–27, 29, 30, 32–36]. The
multivariable analyses were based on previously col-
lected data from administrative databases, previous stud-
ies’ databases, caregiver surveys, or chart reviews.
The sample sizes ranged from 99 to 1,402,167 patients
(patient deaths). In most studies where non-participation
was reported, the rate ranged from zero to 26 % [2, 12, 13,
22–24, 29, 32, 34]. One study reported that 34 % of the
Fig. 1 Citation Flow Chart. aMeta-analyses were performed if deemed appropriate and if more than one study was available for each determinant. The
number of studies included in each analysis varied according to the number of studies that reported on each determinant
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Table 1 Characteristics of Patients Included in the Studies Evaluating Determinants of Home Death
Author, year, sample size, country Patient population, age (years) male Type of diseasea Place of death NOS quality assessment scaleb
Poulose et al. 2013 [13]
N = 842Singapore
• Palliative home care team recipients
• ≥65: 475 (56 %)
• Male: 405 (48 %)
• Cancer: 729 (87 %)
• Non-cancer: 113 (13 %)
• Home: 241 (29 %)
• Hospital: 452 (54 %)
• Inpatient hospice: 149 (17 %)
• 7
Seow et al. 2014c [36]
N = 6,218Canada
• Home care recipients
• Median (IQR): 75: (64–84)
• Male: 3,009 (48 %)
• Cancer: 4,950 (80 %)
• Non-cancer: 1,268 (20 %)
• Outside of hospital: 4,828 (78 %)
• Hospital: 1,390 (22 %)
• 7
Taylor et al. 2011 [17]
N = 1,268New Zealand
• Hospice care recipients
• ≥55: 1,108 (88 %)
• Male: 603 (48 %)
• Cancer: 1,036 (82 %)
• Cardiovascular: 54 (4 %)
• Respiratory: 45 (4 %)
• Other: 120 (10 %)
• Home: 352 (28 %)
• Hospital : 675 (53 %)
• Nursing home: 203 (16 %)
• 7
Houttekier et al. 2011 [19]
N = 189,884Belgium
• General end-of-life population
• ≥65: 54,311 (83 %)d
• Male: 32,718 (50 %)d
Cause of death
• Cancer: 18,321 (28 %)d
• Cardiovascular:16,813 (26 %)d
• Other: 30,100 (46 %)d
• Home: 14,726 (23 %)d
• Hospital: 33,856 (52 %) d
• Nursing home: 14,792 (23 %)d
• Other: 2,061 (3 %)d
• 6
Ikezaki et al. 2011 [21]
N = 4,175Japan
• Receiving home care from nurses
• Mean: 84 ± 10e
• Male: 2,192 (53 %)
• Cancer: 1,664 (40 %)
• Cardiovascular: 504 (12 %)
• Pneumonia: 481 (12 %)
• Other: 1,509 (36 %)
• Home: 1,930 (46 %)
• Hospital: 2,245 (54 %)
• 7
Cardenas-Turanza et al. 2011 [22]
N = 473Mexico
• General end-of-life population
• Mean (SD): 74 (73)
• Male: 235 (50 %)
Cause of death
• Cancer: 91 (19 %)
• Cardiovascular: 104 (22 %)
• Other: 278 (58 %)
• Home: 250 (53 %)
• Hospital: 223 (47 %)
• 8
Fukui et al. 2011 [23]
N = 568Japan
• Receiving home palliative care from nurses
• Mean (SD): 73 (12)
• Male: 339 (60 %)
• Cancer: 100 % • Home: 312 (55 %)
• Hospital: 256 (45 %)
• 8
Hong et al. 2011 [12]
N = 52,120Singapore
• General end-of-life population
• ≥65: 33,938 (65 %)
• Male: 28,987 (56 %)
• Cancer: 100 % • Home: 15,801 (30 %)
• Hospital: 27,592 (53 %)
• Inpatient Hospice: 5,592 (11 %)
• Other: 3,135 (6 %)
• 6
Houttekier et al. 2010 [20]
N = 1,690Belgium
• General end-of-life population
• ≥65: 1,462 (88 %)
• Male: 839 (50 %)
Cause of death
• Cancer: 725 (43 %)
• Cardiovascular: 237 (14 %)
• Other: 728 (43 %)
• Home: 402 (24 %)
• Hospital: 664 (39 %)
• Nursing home: 451 (27 %)
• Palliative care unit: 171 (10 %)
• 7
Houttekier et al. 2010 [18]
N = 237,579fNetherlands/England
• General end-of-life population
• ≥70: 131,574 (73 %)
• Male: 90,619 (50 %)
Cause of death
• Cancer: 170,339 (72 %)
• Heart failure: 11,599 (7 %)
• Other: 52,454 (22 %)
• Home: 49,036 (21 %)
• Hospital: 114,401 (48 %)
• Nursing home: 39,256 (17 %)
• Other: 34,886 (14 %)
• 6
Tang et al. 2010 [25]
N = 201,252Taiwan
• General end-of-life population
• ≥65: 119,690 (59 %)
• Male: 129,354 (64 %)
• Cancer: 100 % • Home: 68,139 (34 %)
• Hospital: 133,113 (66 %)
• 7
Hayashi et al. 2011 [26]
N = 99Japan
• Home care service recipients
• Mean (SD): 78 (13)
• Male: 49 (50 %)
• Cancer: 38 (38 %)
• Ischemic heart disease: 19 (19 %)
• Other: 42 (42 %)
• Home: 40 (40 %)














Table 1 Characteristics of Patients Included in the Studies Evaluating Determinants of Home Death (Continued)
Bell et al. 2009 [27]
N = 1,352United States
• General end-of-life population
• Mean: 84
• Male: 100 %
Cause of death
• Cancer: 337 (25 %)
• Coronary: 181 (13 %)
• Other: 834 (62 %)
• Home: 306 (23 %)
• Hospital: 800 (59 %)
• Nursing home: 246 (18 %)
• 5
Lin et al. 2007 [29]
N = 697,814Taiwan
• General end-of-life population
• ≥75: 423,552 (61 %)
• Male: 290,394 (42 %)
• Cancer: 143,529 (21 %)
• Circulatory: 185,679 (27 %)
• Respiratory: 85,763 (12 %)
• Other: 279,126 (40 %)
• Home; 459,005 (66 %)
• Hospital: 238,809 (34 %)
• 7
Gruneir et al. 2007 [30]
N = 1,402,167United States
• General end-of-life population
• ≥75: 810,453 (58 %)
• Male: 671,638 (48 %)
Cause of death
• Cancer: 351,944 (25 %)
• Cardiovascular: 427,661 (31 %)
• Other: 623,964 (44 %)
• Home: 330,447 (24 %)
• Hospital: 740,405 (53 %)
• Nursing home: 331,315 (24 %)
• 7
Motiwala et al. 2006 [32]
N = 58,689Canada
• General end-of-life population
• ≥75: 43,071 (73 %)
• Male: 27,749 (47 %)
• Cancer: 19,966 (34 %)
• Dementia: 16,267 (28 %)
• Other: 22,302 (38 %)
Not available • 8
Cohen et al. 2006 [33]
N = 55,759Belgium
• General end-of-life population
• ≥65: 46,271 (83 %)
• Male: 28,248 (51 %)
Cause of death
• Cancer: 15,008 (27 %)
• Cardiovascular: 15,846 (28 %)
• Other: 27,793 (45 %)
• Home: 13,549 (24 %)
• Hospital: 29,943 (54 %)
• Nursing home: 11,041 (20 %)
• Other: 1,115 (2 %)
• 6
Brazil et al. 2005 [2]
N = 214Canada
• Home palliative care recipients
• ≥50 year: 100 %
• Male: 142 (66 %)
• Cancer: 207 (96 %)
• Non-cancer: 7 (4 %)
• Home: 120 (56 %)
• Institution: 94 (44 %)
• 8
Klinkenberg et al. 2005 [34]
N = 270Netherlands
• General end-of-life population
• ≥80: 168 (62 %)
• Male: 167 (62 %)
Cause of death
• Cancer: 65 (24 %)
• Non-cancer: 201 (76 %)
• Home: 135 (50 %)
• Hospital: 86 (32 %)
• Nursing home: 46 (17 %)
• 7
Aabom et al. 2005 [35]
N = 4,386Denmark
• Home residents
• >65: 2,979 (68 %)
• Male: 2,145 (49 %)
• Cancer: 100 % • Home: 1,221 (28 %)
• Hospital: 2,412 (55 %)
• Nursing home: 702 (16 %)
• 7
Fukui et al. 2004 [24]
N = 428Japan
• Home care recipients
• Mean (SD): 75 (11)
• Male: 247 (58 %)
• Cancer: 100 % • Home: 285 (67 %)
• Hospital: 143 (33 %)
• 7
Abbreviations: IQR inter-quartile range, NOS Newcastle-Ottawa Scale, SD standard deviation
aCause of death was used for some of the studies (as specified), if this information was reported instead of type of disease
bAdditional details in Additional file 4
cThe study was originally included based on data from a 2013 conference abstract, however, the results of its subsequent publication in the peer-reviewed literature in 2014 was incorporated in our analyses. [36]
d2007 data shown (N = 65,435)
enon-cancer patients data shown (N = 2,511)













Table 2 Characteristics of patients included in the studies evaluating determinants of nursing home death
Author, year, sample size country Patient population, age (years) male Type of diseasea Place of death NOS quality assessment scaleb
Ikegami et al. 2012 [14]
N = 1,158 Japan
• Nursing home residents
• Mean (SD): 89 (8)
• Male: 342 (30 %)
Cause of death
• Cancer: 81 (7 %)
• Cardiovascular: 220 (19 %)
• Pneumonia: 237 (21 %)
• Other: 620 (53 %)
• Nursing home: 548 (47 %)
• Hospital: 610 (53 %)
• 6
Levy et al. 2012 [15]
N = 7,408 United States
• Nursing home residents
• Median (range): 78 (21–105)
• Male: 7,224 (98 %)
Patients with different diseases,
proportions not provided
• Hospital: 995 (13 %)
• Nursing home: 6,413 (87 %)
• 6
Houttekier et al. 2011 [19]
N = 79,846 Belgium
• General end-of-life population
• ≥65: 54,311 (83 %)c
• Male: 32,718 (50 %)c
Cause of death
• Cancer: 18,321 (28 %)c
• Cardiovascular:16,813 (26 %)c
• Other: 30,100 (46 %)c
• Home: 14,726 (23 %)c
• Hospital: 33,856 (52 %) c
• Nursing home: 14,792 (23 %)c
• 6
Houttekier et al. 2010 [20]
N = 1,690 Belgium
• Nursing home residents
• ≥65: 1,462 (88 %)
• Male: 839 (50 %)
Cause of death
• Cancer: 725 (43 %)
• Cardiovascular: 237 (14 %)
• Other: 728 (43 %)
• Home: 402 (24 %)
• Hospital: 664 (39 %)
• Nursing home: 451 (27 %)
• Palliative care unit: 171 (10 %)
• 7
Houttekier et al. 2010 [18]
N = 237,579d
Netherlands/England
• General end-of-life population
• ≥70: 131,574 (73 %)
• Male: 90,619 (50 %)
Cause of death
• Cancer: 170,339 (72 %)
• Heart failure: 11,599 (7 %)
• Other: 52,454 (22 %)
• Home: 49,036 (21 %)
• Hospital: 114,401 (48 %)
• Nursing home: 39,256 (17 %)
• Other: 34,886 (14 %)
• 6
Bell et al. 2009 [27]
N = 1,352 United States
• General end-of-life population
• Mean: 84
• Male: 100 %
Cause of death
• Cancer: 337 (25 %)
• Coronary: 181 (13 %)
• Other: 834 (62 %)
• Home: 306 (23 %)
• Hospital: 800 (59 %)
• Nursing home: 246 (18 %)
• 5
Kwak et al. 2008 [28]
N = 30,765 United States
• Nursing home residents
• Mean (SD): 86 (8)
• Male: 8,306 (27 %)
Cause of death
• Cancer: 1,661 (5 %)
• Cardiovascular: 11,291 (37 %)
• Other: 17,844 (58 %)
• Home: 615 (2 %)
• Nursing home: 21,228 (69 %)
• Hospital: 8,307 (27 %)
• Other: 615 (2 %)
• 7
Takezako et al. 2007 [31]
N = 86 Japan
• Nursing home residents
• ≥85: 53 (62 %)
• Male: 20 (23 %)
• Cancer: 3 (4 %)
• Cardiovascular: 20 (23 %)
• Cerebrovascular: 35 (41 %)
• Other: 28 (33 %)
• Nursing home: 43 (50 %)
• Hospital: 43 (50 %)
• 8
Motiwala et al. 2006 [32]
N = 58,689 Canada
• General end-of-life population
• ≥75: 43,071 (73 %)
• Male: 27,749 (47 %)
• Cancer: 19,966 (34 %)
• Dementia: 16,267 (28 %)
• Other: 22,302 (38 %)
• Not available • 8
Levy et al. 2004 [16]
N = 152,494 United States
• Nursing home residents
• ≥65: 146,998 (96 %)
• Male: not available
• Patients with different diseases,
proportions not provided
• Hospital: 51,187 (34 %)
• Nursing home: 101,307 (66 %)
• 7
Abbreviations: NOS Newcastle-Ottawa Scale, SD standard deviation
aCause of death was used for some of the studies (as specified), if this information was reported instead of type of disease
bAdditional details in Additional file 4
c2007 data shown (N = 65,435)













patients were excluded either due to missing data or due
to ineligibility, [30] and 1 study reported that 49 % of
questionnaires mailed were not returned [21]. All studies
identified adjusted for illness-related factors, all but one
study adjusted for sociodemographic factors [26], and only
2 studies (10 %) did not adjust for healthcare service avail-
ability factors [12, 27]. Additionally, 4 (19 %) studies in-
cluded patient and/or family preference for place of death
in the multivariable model [2, 20, 21, 23]. Eleven (48 %)
studies reported on the study time-frame – these studies
used data collected during the last year of the patient’s life
[2, 17, 20, 22, 23, 25, 32, 34–36]. The risk of bias in the
studies was considered low, 4 (19 %) studies received 8
out of 9 stars in the NOS scale, 11 (52 %) received 7 stars,
and 6 (29 %) studies were awarded 5–6 stars (Table 1, de-
tails in Additional file 4). According to the NOS assess-
ment no serious limitations were identified in the patient
selection and outcome assessment, moreover, the study
results were based on multivariable analyses adjusting for
possible confounders.
The studies originated in various countries and/or re-
gions: 3 in Canada [2, 32, 36]; 8 in Asia [12, 13, 21, 23–
26, 29]; 6 in Europe [18–20, 33–35]; 2 in the United
States [27, 30]; 1 in Mexico [22]; and 1 in New Zealand
[17]. Six studies (29 %) were specific to cancer patients
[12, 21, 23–25, 35] and 8 studies (38 %) were restricted
to patients receiving home care [2, 13, 17, 21, 23, 24,
26, 36]. The remainder were not specific to a disease or
setting. The majority of patients included in the studies
were older than 65 years and approximately half were
female.
Home death occurred in 21 % to 78 % of the patients
(Table 1). Four studies (19 %) reported the patient and/
or family preference for place of death [2, 20, 21, 23]; of
those who stated a preference, 26 % to 85 % of patients
preferred a home death, as did 45 % to 65 % of family
members.
Table 3 summarizes the adjusted ORs of home versus
hospital death reported in the studies identified, Figs. 2, 3
and 4 show the forest plots of the meta-analyses per-
formed. The results were stratified according to setting,
i.e., whether the patients were receiving home palliative
care services or not. Factors that were associated with an
increased likelihood of home death included nurse and
family physician home visits, multidisciplinary home pal-
liative care, patient and family preference for home death,
cancer compared to other diseases, timing of referral to
palliative care, worse functional status, not living alone,
presence of an informal caregiver, and caregiver coping.
On the other hand, factors that decreased the likelihood
of home death included hospital admissions in the last
year of life, admission to a hospital with palliative care ser-
vices, and some diseases such as cardiovascular versus
other diseases and hematological cancers compared to
solid tumours. None of the studies identified provided
data on the association between symptoms and home
death.
Determinants of nursing home death
Ten observational studies using multivariable analyses
evaluated the determinants of nursing home versus hos-
pital death. [14–16, 18–20, 27, 28, 31, 32]. These were
retrospective cohort studies based on previously col-
lected data from administrative databases or chart re-
views that originated in various countries and regions: 1
in Canada [32]; 3 in Europe [18–20]; 4 in the United
States [15, 16, 27, 28]; and 2 in Japan [21, 31]. None of
the studies were disease-specific, 6 (60 %) were restricted
to nursing home residents [14–16, 20, 28, 31]; the
remaining studies included a general end-of-life popula-
tion some of which were nursing home residents.
The sample sizes ranged from 86 to 237,579. The non-
participation rate was low in the only 2 studies that pro-
vided such data: 1 % [31] and 2 % [32]. All studies identified
adjusted for illness-related factors and healthcare services
availability. Eight studies (80 %) adjusted for sociodemo-
graphic factors [16, 18–20, 27, 28, 31, 32]. Additionally, 5
(50 %) studies included patient and/or family preference for
place of death in the multivariable model [14–16, 20, 31].
Three (30 %) studies provided the study time-frame – these
studies used data collected during the last year of the pa-
tient’s life [20, 28, 32]. The risk of bias in the studies was
considered low, 2 (20 %) studies received 8 out of 9 stars in
the NOS scale, 3 (30 %) received 7 stars, and 5 (50 %) stud-
ies were awarded 5–6 stars (Table 2, details in Additional
file 4). According to the NOS assessment no serious limita-
tions were identified in the patient selection and outcome
assessment, moreover, the study results were based on mul-
tivariable analyses adjusting for possible confounders.
Most of the patients were older than 65 years of age
and between 27 % and 100 % were male. Nursing home
death occurred in 27 % to 87 % of the patients in the
studies restricted to nursing home residents [14–16, 19,
28, 31] and from 17 % to 23 % in the studies in a general
end-of-life population [18, 20, 27, 32]. Details in Table 2.
Table 4 summarizes the adjusted ORs of nursing home
versus hospital death reported in the studies identified,
forest plots are shown in Figs. 5, 6 and 7. The results
were stratified according to setting, i.e., studies restricted
to nursing home residents and studies in a general end-
of-life population. Factors that were associated with an
increased likelihood of nursing home death included pallia-
tive care services available in the nursing home, having
completed an advance directive, patient or family prefer-
ence for nursing home death, some diseases such as de-
mentia, stroke and end-stage disease, functional status,
admission to a hospital-based nursing home, and a longer
duration of stay at the nursing home. Among nursing home
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Table 3 Study results – determinants of home versus hospital death
Determinant Number of Studies Adjusted OR (95 % CI)b
Nurse Home Visits
Nurse home visits in a general end-of-life population (vs. no visits) 1 study 2.78 (2.08–3.85) [35]
Nurse home visits in home care recipients (vs. no visits) 1 study 3.13 (1.08–6.21) [26]
Family Physician Home Visits
Family physician home visits in a general end-of-life population
(vs. no visits)
1 study 12.50 (8.33–16.67) [35]
Family physician home visits in home care recipients 2 studies 1.74 (1.08–2.80) [23]
4.42 (1.46–13.36) [2]
Pooled: 2.01 (1.30–3.12), I2: 57 %
Home Care Teams
Multidisciplinary palliative home care team 2 studies
Vs. usual carea RR 2.17 (1.92–2.50) [36]
Vs. no multidisciplinary home care team 8.40 (4.70–15.10) [20]
In-Hospital Palliative Care
In-hospital palliative support team or hospice unit (yes vs. no) 2 studies 0.34 (0.10–0.90) [20]
0.62 (0.40–0.96) [25]
Pooled: 0.54 (0.33–0.89), I2: 18 %
Preference for Home Death
Patient preference for home death in a general end-of-life
population (vs. no patient preference for home death)
1 study 14.20 (9.50–21.40) [20]
Patient preference for home death in home care recipients
(vs. no patient preference for home death)
2 studies 2.04 (1.48–2.80) [21]
2.92 (1.25–6.84) [2]
Pooled: 2.13 (1.58–2.87), I2: 0
Family preference for home death vs. no family preference for
home death




Congruence between patient and family preference
vs. no preference congruence





Cancer, cardiovascular disease - See Figures 2–3
Major acute condition vs. other conditions 1 study 0.29 (0.26–0.33) [32]
Timing of Referral to Palliative Care
Time from referral to palliative care to death (≥1 vs. < 1 month) 1 study 2.21 (1.34–3.67) [13]
Functional Status
Worse functional status or bedridden (vs. better functional status
or not bedridden)
2 studies 2.22 (1.27–3.87) [23]
1.82 (0.93–3.57) [34]
Pooled: 2.05 (1.33–3.15), I2: 0
Prior Hospital Admission
≥ 1 hospital admission during the last year of life (vs. no admission) 1 study 0.15 (0.07–0.30) [22]
Decision not to re-hospitalize in the event of a crisis (vs. no) 1 study 40.11 (11.81–136.26) [24]
Informal Caregiver-Related
Presence of informal caregiver (often vs. none or sometimes) 1 study 2.30 (1.20–4.60) [20]
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residents, with the exception of one study [19], a higher
likelihood of a nursing home death was observed in pa-
tients with cancer compared to patients with other diseases
across the studies identified (Figure 6) [15, 16, 20, 28]. Ex-
cluding the result of that study [19] yielded a pooled OR
for nursing home versus hospital death of 1.91 (95 % CI:
1.69–2.16), and decreased the I2 from 99 % to 58 %. In con-
trast, within a general end-of-life population not restricted
to nursing home residents, there was a trend towards a
lower likelihood of dying in the nursing home compared to
hospital in cancer versus non-cancer patients (Figure 6). In-
conclusive results were observed for the association be-
tween nursing home death and living arrangements. None
of the studies identified provided data on the association
between symptoms and nursing home death.
Quality assessment and grading of the evidence
The evidence identified consisted of observational stud-
ies based, in most cases, on large databases. Neverthe-
less, as per the NOS assessment, given that no serious
limitations were identified in either the patient selection
or outcome assessment, and considering that the results
reported were based on multivariable analyses adjusting
for factors that had previously been identified as affect-
ing place of death, we considered the risk of bias to be
low. Non-participation was not considered a serious risk
of bias since, given the nature of the studies being based
on large databases, non-participation was not believed to
be related to either the exposure or outcome.
The quality of the body of evidence was considered low
to very low. According to the GRADE Working Group
criteria [10], observational studies are considered low
quality. In our assessment, the quality of the evidence was
downgraded to very low in a few instances due to either
imprecision or inconsistencies in the study results (i.e., as-
sociation between caregiver health and home death; care-
giver satisfaction with support from family physician and
home death; living arrangements and nursing home death).
Otherwise, no downgrading of the quality of the evidence
was deemed necessary as no serious limitations were iden-
tified for risk of bias, inconsistency, indirectness, or impre-
cision. No evidence of publication bias was observed.
Fig. 2 Forest Plot of the Association Between Disease Type and Home Death. Abbreviations: CI, confidence interval; df, degrees of freedom; IV,
inverse variance; SE, standard error
Table 3 Study results – determinants of home versus hospital death (Continued)
Low informal caregiver psychological distress during stable phase
(vs. high distress)
1 study 5.41 (1.13–25.92) [24]
Informal caregiver satisfaction with support from family physician (vs. dissatisfaction) 1 study 1.62 (0.31–8.62) [2]
Informal caregiver health (excellent/very good vs. fair/poor) 1 study 0.64 (0.20–1.99) [2]
Living Arrangements
See Figure 4
Abbreviations: CI confidence interval, OR odds ratio, RR relative risk, vs versus
aConsisting of home care without involvement from palliative care teams [36]
bThe reciprocal of the OR or RR and 95 % CI provided in the study was used in very few instances where necessary to ensure consistency of reporting; for
instance if the OR of hospital vs. home death was provided instead of the OR of home vs. hospital death, or if the OR for non-cancer as type of disease was
provided instead of cancer (OR home vs. hospital death = 1/OR hospital vs. home death) [37]
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Fig. 3 Forest Plot of the Association Between Cancer and Home Death. Abbreviations: CI, confidence interval; df, degrees of freedom; IV, inverse
variance; SE, standard error
Fig. 4 Forest Plot of the Association Between Living Arrangements and Home Death. Abbreviations: CI, confidence interval; df, degrees of freedom; IV,
inverse variance; SE, standard error. Results for cancer patients used in the study by Cohen et al. [33]
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Table 4 Study results – determinants of nursing home versus hospital death
Determinant Number of Studies Adjusted OR (95 % CI)a
End-of-Life, Palliative or Hospice Care in the Nursing Home
See Figure 5
Advance Directives
Among nursing home residents 1 study 1.57 (1.35–1.82) [15]
Any advance directive (vs. no advance directive)
Do-not-resuscitate order (yes vs. no) 1 study 3.33 (3.33–3.45) [16]
Do-not-hospitalize order (yes vs. no) 1 study 5.26 (4.76–5.88) [16]
Preference for Nursing Home Death
Among nursing home residents
Patient preference (yes vs. no) 1 study 10.40 (4.40–24.90) [20]
Family preference (yes vs. no) 1 study 16.62 (11.38–24.27) [14]
Disease-Related
Cancer, dementia (vs. other diseases) See Figures 6–7
End-stage disease (vs. non-end-stage) 1 study 3.90 (2.78–5.47) [15]
Stroke vs. other diseases (nursing home residents) 1 study 1.12 (1.06–1.18) [16]
Stroke vs. other diseases (general end-of-life population) 1 study 4.76 (2.38–9.09) [27]
Heart Failure vs. other diseases (nursing home residents) 1 study 0.75 (0.65–0.88) [15]
Diabetes vs. other diseases (nursing home residents) 2 studies 0.70 (0.61–0.81) [15]
0.90 (0.87–0.93) [16]
Pooled: 0.80 (0.63–1.03), I2: 91 %
Functional Status
Worse functional status or bedridden vs. better functional
status or not bedridden (nursing home residents)
2 studies 2.80 (0.83–9.49) [31]
2.22 (2.04–2.38) [16]
Pooled: 2.22 (2.07–2.38), I2: 0
Nursing Home Characteristics
Hospital-based nursing home (nursing home residents) 1 study 1.21 (1.15–1.25) [16]
Full-time physician presence (nursing home residents) 1 study 3.74 (1.03–13.63 [31]
Nursing Home Stay
1-month increment (nursing home residents) 1 study 1.01 (1.01–1.01) [15]
≥ 3 vs. < 3 months (nursing home residents) 1 study 1.44 (1.36–1.53) [28]
Living Arrangements
Living at home before nursing home (vs. not living at home) 1 study 2.97 (0.87–10.19) [31]
Married vs. unmarried 2 studiesb 0.35 (0.07–1.64) [31]
1.08 (1.00–1.16) [28]
Abbreviations: CI confidence interval, OR odds ratio, vs versus
aThe reciprocal of the OR or RR and 95 % CI provided in the study was used in very few instances where necessary to ensure consistency of reporting; for
instance if the OR of hospital vs. home death was provided instead of the OR of home vs. hospital death, or if the OR for non-cancer as type of disease was pro-
vided instead of cancer (OR home vs. hospital death = 1/OR hospital vs. home death) [37]
bStudy results were not pooled due to considerable heterogeneity, i.e., inconsistency in the direction of the study results (1 study with results favouring nursing
home deaths and 1 study with results favouring hospital deaths)
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Discussion
Summary of the evidence
In this systematic review of the literature, we identified
factors that were associated with home and nursing
home death. This systematic review corroborates the re-
sults of two past systematic reviews while contributing
with additional results in non-cancer populations and
evaluating the determinants of nursing home death.
Nevertheless it should be noted that approximately a
third of the studies included solely cancer patients, and
4 (14 %) other studies included at least 50 % of cancer
patients. Therefore caution should be used when gener-
alizing these results to more specific disease populations,
especially as our results suggest that cancer patients may
be more likely to die at home than in hospital compared
to non-cancer patients.
Limitations
We only included studies that adjusted the results for
other factors potentially associated with place of death as
per a conceptual model [3]. Nonetheless, the analyses
were constrained by the variables included in the original
Fig. 6 Forest Plot of the Association Between Cancer and Nursing Home vs. Hospital Death. Abbreviations: CI, confidence interval; df, degrees of
freedom; IV, inverse variance; SE, standard error
Fig. 5 Forest Plot of the Association Between Availability of Palliative Care Services in the Nursing Home and Nursing Home vs. Hospital Death in
Nursing Home Residents. Abbreviations: CI, confidence interval; df, degrees of freedom; IV, inverse variance; SE, standard error
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studies, for instance, although most studies adjusted for
factors related to the illness, individual, and the environ-
ment, few studies adjusted for patient or family preference
regarding place of death. One of the limitations inherent
to this literature is the reliance on observational and often
retrospective studies. The lack of randomized controlled
trials (RCTs) in the literature may have been due to the
fact that many determinants evaluated do not consist of
interventions that patients can be assigned to. Some of the
factors evaluated such as availability of palliative care in
the place of residence or home visits by healthcare
personnel may be amenable to an RCT design, however,
possible difficulties in performing an RCT in end-of-life
circumstances may have hindered this type of investiga-
tion. Considerable heterogeneity was observed in some of
the meta-analyses undertaken, which may be due to the
narrow confidence intervals stemming from the large
sample sizes. Heterogeneity could not be further explored
by meta-regression given the relatively small number of
studies available for each determinant. Although studies
from different countries were used in our analyses we
noted that the direction of the effect for the different de-
terminants was consistent across countries. Despite in-
cluding studies from different countries, by restricting our
literature search to publications in English, studies from
some countries may have been unintentionally excluded,
which may limit the generalizability of the results to such
contexts. Our analyses did not directly focus on cultural
and demographic factors such as patient age and sex, eth-
nicity, and socioeconomic status, however, these factors
were accounted for in the analyses as most studies ad-
justed for at least some subset of them in their multivari-
able analyses.
Clinical practice and policy implications
Studies have shown that satisfaction with end-of-life care
is improved when patients die in their preferred location
[7], and information on determinants of place of death
identified in these analyses may be used by policy makers
to attempt to create conditions that enable patients’ dying
in their preferred location.
Place of death, per se, may not be a very good indica-
tor of the quality of end-of-life/palliative care since it is
determined by a complex array of factors, some of which
are not very modifiable, therefore the appropriate place
of death being dependent on individual circumstances.
Some factors identified in our analyses are related to
the illness and may not be modifiable, for instance type
of disease, living arrangements, and the presence of
symptoms that result in frequent hospital admissions.
However, it may still be important to keep these factors
in mind when discussing the feasibility of dying in the
location of preference with patients and family members.
On the other hand, if feasible, some of the factors identi-
fied can be acted upon in order to improve the likeli-
hood that the patient’s preferences will be met.
Modifiable factors include the presence of a multidiscip-
linary palliative care team in the home and the availabil-
ity of palliative care services in the nursing home,
providing support to the patient and caregiver, and a
timely referral to palliative care services.
Conclusions
The location of death depends on multiple factors that
include the patients’ sociodemographic characteristics,
social support, as well as illness- and healthcare-related
factors. Having an understanding of these factors better
informs the discussions among healthcare providers, pa-
tients and their families regarding patient preferences
and the feasibility of dying in the preferred location and
may perhaps help explain the incongruence between
preferred and actual place of death.
Additionally, modifiable factors such as early referral
to palliative care and presence of a multidisciplinary pal-
liative care team in the patient's residence, among others
were identified. Applying these interventions may im-
prove the likelihood of a patient dying in the preferred
location.
Fig. 7 Forest Plot of the Association Between Type of Disease and Nursing Home vs. Hospital Death
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